如果你知道你还会看到：群体药代动力学是血友病预防个性化和优化的方法。 - Suppr

Suppr

超能文献

If you know you will also see: population pharmacokinetics is the way to personalize and optimize prophylaxis in hemophilia.

作者信息

Berntorp E

机构信息

Department of Translational Medicine, Lund University, Malmö Center for Thrombosis and Hemostasis, Malmö, Sweden.

出版信息

J Thromb Haemost. 2017 Jun;15(6):1103-1105. doi: 10.1111/jth.13682. Epub 2017 Apr 21.

DOI:10.1111/jth.13682

PMID:28339167

Abstract

摘要

相似文献

If you know you will also see: population pharmacokinetics is the way to personalize and optimize prophylaxis in hemophilia.如果你知道你还会看到：群体药代动力学是血友病预防个性化和优化的方法。

J Thromb Haemost. 2017 Jun;15(6):1103-1105. doi: 10.1111/jth.13682. Epub 2017 Apr 21.

Joint Aspiration for Acute Hemarthrosis in Children Receiving Factor VIII Prophylaxis for Severe Hemophilia: 11-year Safety Data.接受重度血友病因子 VIII 预防性治疗的儿童急性关节积血的关节穿刺术：11 年安全性数据

J Rheumatol. 2015 May;42(5):885-90. doi: 10.3899/jrheum.141236. Epub 2015 Mar 1.

Bleeds and imaging scoring scales in relation to pharmacokinetics of coagulation factor VIII in Chinese pediatric patients with severe hemophilia A.

Thromb Res. 2020 Sep;193:83-85. doi: 10.1016/j.thromres.2020.05.043. Epub 2020 May 28.

Importance of pharmacokinetics in the management of hemophilia.药物动力学在血友病管理中的重要性。

Pediatr Blood Cancer. 2013;60 Suppl 1:S27-9. doi: 10.1002/pbc.24339. Epub 2012 Oct 25.

Personalized prophylaxis in people with hemophilia A: challenges and achievements.血友病 A 患者的个体化预防：挑战与成就。

Expert Rev Hematol. 2016 Dec;9(12):1203-1208. doi: 10.1080/17474086.2016.1252670. Epub 2016 Nov 4.

Hemarthrosis in acquired hemophilia. Two case-reports.

Joint Bone Spine. 2003 Dec;70(6):532-4. doi: 10.1016/s1297-319x(03)00057-5.

Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study.重度甲型血友病的个体化预防：加拿大血友病初级预防研究前5年的中期结果。

J Thromb Haemost. 2006 Jun;4(6):1228-36. doi: 10.1111/j.1538-7836.2006.01953.x.

An approach to target joint bleeding in hemophilia: prophylaxis for all or individualized treatment?

J Pediatr. 2004 Nov;145(5):581-3. doi: 10.1016/j.jpeds.2004.08.040.

Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A.用于预防和治疗重度 A 型血友病儿童出血的重组凝血因子 VIII Fc 融合蛋白。

J Thromb Haemost. 2015 Jun;13(6):967-77. doi: 10.1111/jth.12911. Epub 2015 Apr 23.

Prophylaxis: the next haemophilia treatment.

J Intern Med. 1992 Jul;232(1):1-2. doi: 10.1111/j.1365-2796.1992.tb00543.x.

引用本文的文献

Relationship between factor VIII levels and bleeding for rFVIII-SingleChain in severe hemophilia A: A repeated time-to-event analysis.FVIII-SingleChain 在重度 A 型血友病患者中因子 VIII 水平与出血的关系：一项重复的事件时间分析。

CPT Pharmacometrics Syst Pharmacol. 2023 May;12(5):706-718. doi: 10.1002/psp4.12938. Epub 2023 Mar 25.

Impact of pharmacokinetics to reduce bleeding in a cohort of patients with severe hemophilia A in a personalized comprehensive management program.在个性化综合管理项目中，药代动力学对一组重度甲型血友病患者减少出血的影响。

Hematol Rep. 2021 Nov 26;13(4):8904. doi: 10.4081/hr.2021.8904.

Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic-pharmacodynamic model for patients with haemophilia A.结合因子 VIII 水平和凝血酶/纤溶酶生成：血友病 A 患者的群体药代动力学-药效学模型。

Br J Clin Pharmacol. 2022 Jun;88(6):2757-2768. doi: 10.1111/bcp.15185. Epub 2022 Jan 15.

Pharmacokinetics in routine haemophilia clinical practice: rationale and modalities-a practical review.血友病常规临床实践中的药代动力学：原理与模式——实践综述

Ther Adv Hematol. 2020 Oct 20;11:2040620720966888. doi: 10.1177/2040620720966888. eCollection 2020.

Favorable Pharmacokinetic Characteristics of Extended-Half-Life Recombinant Factor VIII BAY 94-9027 Enable Robust Individual Profiling Using a Population Pharmacokinetic Approach.延长半衰期重组凝血因子 VIII BAY 94-9027 的有利药代动力学特征使其能够通过群体药代动力学方法进行稳健的个体分析。

Clin Pharmacokinet. 2020 May;59(5):605-616. doi: 10.1007/s40262-019-00832-7.

Bayesian Forecasting Utilizing Bleeding Information to Support Dose Individualization of Factor VIII.贝叶斯预测利用出血信息支持因子 VIII 的剂量个体化。

CPT Pharmacometrics Syst Pharmacol. 2019 Dec;8(12):894-903. doi: 10.1002/psp4.12464. Epub 2019 Oct 30.

Relationship between factor VIII activity, bleeds and individual characteristics in severe hemophilia A patients.重度 A 型血友病患者因子 VIII 活性、出血与个体特征之间的关系。

Haematologica. 2020 May;105(5):1443-1453. doi: 10.3324/haematol.2019.217133. Epub 2019 Aug 1.

The role of orthopaedic surgery in haemophilia: current rationale, indications and results.骨科手术在血友病中的作用：当前的理论依据、适应症及结果

EFORT Open Rev. 2019 May 10;4(5):165-173. doi: 10.1302/2058-5241.4.180090. eCollection 2019 May.

Handling interoccasion variability in model-based dose individualization using therapeutic drug monitoring data.利用治疗药物监测数据处理基于模型的剂量个体化中的间变异性。

Br J Clin Pharmacol. 2019 Jun;85(6):1326-1336. doi: 10.1111/bcp.13901. Epub 2019 Apr 29.

Hemophilia Care in the Pediatric Age.儿童期血友病护理

J Clin Med. 2017 May 19;6(5):54. doi: 10.3390/jcm6050054.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验